PDCD1LG2 and glioblastoma: The first new observation was that the basal expression level of the examined immune suppressive checkpoint molecules PD-L1, PD-L2, and HVEM is different in glioblastoma cells, with the highest levels of expression of PD-L1 and PD-L2 on HROG-06 cells (Fig. 2a).